Screen Reader Access
About us
Profile
Mission & Vision
Organisation Structure
Parent Organisation
Former Directors
Campus Tour
People
Director
Our Scientsts
Research Divisions
Cancer Biology
Endocrinology
Medicinal & Process Chemistry
Neuroscience & Ageing Biology
Pharmaceutics & Pharmacokinetics
Pharmacology
Toxicology & Experimental Medicine
Virus Research and Therapeutics
Sophisticated Analytical Instrument Facility & Research
Laboratory Animal Facility
Biochemistry & Structural Biology
Molecular Microbiology & Immunology
Infrastructural Support Group
Academic Affair Unit
BD & IP Unit
Computer Centre
Knowledge Resource Centre (Library)
Human Resource Development
Scientific Directorate
Administration
Technical & support Staff
Research
Malaria and other Parasitic Diseases
Antimicrobial Resistance
Virus Research and Therapeutics
Cancer
Neuroscience and Ageing Biology
Cardiovascular System disorders
Bone Health
Reproductive Health
Pre-clinical Studies and Translation
Achievement
Drug
Technology
Diagnostics
Patent Applications
Publications
Honours & Awards
Product Pipeline
Small molecule
Phytopharmaceuticals
Novel formulations
Patent Applications
Business
Modes of Collaboration
Technologies Licensed
Glimpses
Contract Research
Consultancy
Services
Biological Screening
MoU list
Facilities & Services
Sophisticated Instrument Facility
SAIF Lucknow
Electron Microscopy
NMR Spectroscopy
Mass Spectrometry
X-Ray Crystallography
Digital Library of Indian Medicinal Plants
Tandem Mass Spectrum Database
Laboratory Animal Center
Biological screening
Bio Info & Computational Biology
MAOs & MAEs for Embryology
Pre Clinical Regulatory Studies
Clinical Trial Centers
GLP Facility
Career
Prospective Scientist
Career Growth Opportunities
Prospective Scholar
PhD Program
Director's Message
Why CSIR-CDRI
Frequently Asked Questions
Campus Tour
Facilities
Prospective Project Staff
International Scholar
Introduction
Guidelines
Undertaking
Contact
Advance Training Programme
Training for Scholarship Awardees
Skill Development Program
Healthcare & Life Sciences
Postgraduate Students
Contact
Home
About us
Profile
Mission & Vision
Organisation Structure
Parent Organisation
Former Directors
Campus Tour
People
Director
Our Scientsts
Research Divisions
Cancer Biology
Endocrinology
Medicinal & Process Chemistry
Neuroscience & Ageing Biology
Pharmaceutics & Pharmacokinetics
Pharmacology
Toxicology & Experimental Medicine
Virus Research & Therapeutics
Sophisticated Analytical Instrument Facility & Research
Laboratory Animal Facility
Biochemistry & Structural Biology
Molecular Microbiology & Immunology
Infrastructural Support Group
Academic Affair Unit
BD & IP Unit
Computer Centre
Knowledge Resource Centre (Library)
Human Resource Development
Scientific Directorate
Administration
Technical & support Staff
Research
Malaria and other Parasitic Diseases
Antimicrobial Resistance
Virus Research & Therapeutics
Cancer Biology
Neuroscience and Ageing Biology
Cardiovascular System disorders
Bone Health
Reproductive Health
Pre-clinical Studies and Translation
Achievements
Drugs
Technologies
Diagnostics
Patents
Publications
Honours & Awards
Product Pipeline
Small molecule
Phytopharmaceuticals
Novel formulations
Patent Applications
Business
Modes of Collaboration
Technologies Licensed
Glimpses
Contract Research
Consultancy
Services
Biological Screening
MoU list
Career
Prospective Scientist
Career Growth Opportunities
Prospective Scholar
PhD Program
Director's Message
Why CSIR-CDRI
Frequently Asked Questions
Campus Tour
Facilities
Prospective Project Staff
International Scholar
Introduction
Guidelines
Undertaking
Contact
Prospective Trainee
Advanced training
Skill Development Program
Healthcare & Life Sciences
Postgraduate Students
Facilities & Services
Sophisticated Instrument Facility
SAIF Lucknow
Electron Microscopy
NMR Spectroscopy
Mass Spectrometry
X-Ray Crystallography
Digital Library of Indian Medicinal Plants
Tandem Mass Spectrum Database
Laboratory Animal Center
Biological Screening
Bio Info & Computational Biology
MAOs & MAEs for Embryology
Pre Clinical Regulatory Studies
Clinical Trial Centers
GLP Facility
Infrastructural Support Group
Academic Affair Unit
BD & IP Unit
Computer Centre
Knowledge Resource Centre (Library)
Laboratory Animals
Human Resource Development
Scientific Directorate
Contact
Lead Compound S011-1793 (Antimalarial)
Lead Compound S011-1793 (Antimalarial)
Unique Features of the Molecule:
➤ Exhibits activity against drug-resistant
P. falciparum
lines
in vitro
➤ Curative against chloroquine-resistant parasite strain in mouse model
➤ Molecule has good solid state properties
➤
in vitro
ADME parameters have indicated favourable drug-like profile with no off-target ion channel activities
Executive Summary
A novel 4-aminoquinoline derivative exhibiting curative activity against drug resistant malaria has been identified for preclinical development as a blood schizontocidal agent. The lead molecule, selected after detailed SAR studies, has good solid state properties and has promising activity against
in vitro
and
in vivo
experimental malaria models. The
in vitro
ADME parameters have indicated favourable drug-like profile with no off–target ion channel activities.
Scientific Basis of the Project
Aminoquinolines such as chloroquine had been the most important animalarials for more than four decades in view of their efficacy against all species of human malaria and their safety profile. Emergence of resistance to this class of compounds during 1980’s created a genuine health crisis in the developing world. Studies on elucidation of mechanism of resistance and general trend emerging from the SAR-studies revealed that chloroquine resistance does not involve any change to the target of this class of drugs but involves compound specific efflux mechanism. Based on this premise a number of research groups have developed short chain analogues of 4-aminoquinoline, which are active against CQ-resistant strains of
P. falciparum
. However, these derivatives undergo biotransformation (de-alklylation) significantly affecting lipid solubility of the drug. In view of this background information, we introduced modification in the side chain that would prevent de-alkylation leading to improved activity. This prompted us to explore the amino acid conjugates with a view to achieve improved antimalarial activity and to the best of our knowledge such amino acid conjugates have not been hitherto reported in the literature in the case of 4-aminoquinolines. The seminal finding of our study is that a new series of compounds having significant activity against CQ resistant parasites has been identified.
Intellectual Property Right Protection (IPR)/ Patent Status:
Patent Filed: 4-Amino quinolines and process of preparation thereof Indian Application No. 2291DEL2013 Dt. 31 Jul 13